Immune Netw.  2004 Mar;4(1):31-37. 10.4110/in.2004.4.1.31.

Adoptive Transfer of Colon Cancer Derived Peptide-specific CD8+ T Cells in HHD Mice

Affiliations
  • 1School of Life and Food Sciences, Handong Global University, Pohang, Korea. msdo@handong.edu
  • 2AIDS-retrovirus Department, Antiviral Cellular Unit, Pasteur Institute, Paris, France.
  • 3Department of Immunology, The Weizmann Institute of Science, Rehovot 76100, Israel.

Abstract

BACKGROUND
1-8D gene is a member of human 1-8 interferon inducible gene family and is shown to be overexpressed in fresh colon cancer tissues. Three peptides 1-6, 3-5 and 3-7 derived from 1-8D gene were shown to have immunogenicity against colon cancer. METHODS: To study tumor immunotherapy of these peptides we established an adoptive transfer model. D(b-/-)Xbeta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/D(b)-beta2m single chain (HHD mice) were immunized with irradiated peptide-loaded RMA-S/HHD/B7.1 transfectants. Spleens were removed after last immunization, and splenocytes were re-stimulated in vitro. Lymphocytes from vaccinated HHD mice were transferred together with IL-2 to the tumor bearing nude mice that were challenged S.C. with the HCT/HHD/B7 colon carcinoma cell line that was found to grow in these mice. RESULTS: Peptide 3-5 was found to be highly effective in CTL activity. Adoptively transferred anti-peptide 3-5 cytolytic T lymphocytes caused significant retardation in tumor growth. CONCLUSION: This study shows that peptide 3-5 can be the most effective candidate for the vaccine of adoptive immunotherapy against colon cancer.

Keyword

1-8D gene; HHD mice; colon caner; cytotoxic T lymphocyte; adoptive transfer

MeSH Terms

Adoptive Transfer*
Animals
Cell Line
Colon*
Colonic Neoplasms*
Humans
Immunization
Immunotherapy
Immunotherapy, Adoptive
Interferons
Interleukin-2
Lymphocytes
Mice*
Mice, Nude
Peptides
Spleen
T-Lymphocytes*
Interferons
Interleukin-2
Peptides
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr